The Department of Health and Human Services is seeking information on cloud hosting options to migrate and field services in a bid to support public health emergency response activities.
Moderna Therapeutics has secured a potential five-year, $125 million contract from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response to produce a vaccine for the Zika virus. HHS said Wednesday ASPR’s Biomedical Advanced Research and Development Authority will help Moderna conduct clinical trial, toxicology studies, vaccine formulation and manufacturing through the contract’s four-year […] More
The Department of Health and Human Services has awarded a potential $16.6 million contract to Orasure Technologies to develop a Zika virus test that will work to show results within 30 minutes and can be conducted at a doctor’s office. HHS said Tuesday OraSure will design its lateral flow serological test to look for Zika antibodies in drops of blood to detect […] More
InBios International has received a two-year, $5.1 million contract from the Department of Health and Human Services to further develop a blood screening technology intended to identify people infected with the Zika virus. HHS’ Office of the Assistant Secretary for Preparedness and Response will fund the serological test being developed by InBios with the goal to speed up […] More
The Department of Health and Human Services is looking for an information sharing and analysis organization to help raise awareness about cybersecurity threats across the government and commercial healthcare sectors. HHS said Monday its Office of the National Coordinator for Health Information Technology and Office of the Assistant Secretary for Preparedness and Response seek to enter into cooperative agreements with a […] More
Medical device manufacturer Terumo BCT has received $17.4 million in initial funds from the Biomedical Advanced Research and Development Authority to conduct a clinical trial on a technology intended to help facilitate platelet treatments in patients. Terumo BCT said Tuesday its Pathogen Reduction Technology system designed to study the clinical effectiveness of standard platelets in plasma compared to Mirasol-treated platelets in plasma for patients […] More